The Paracetamol Industry in China
Paracetamol, the active ingredient that contained in more than 100 natural herbs, was found by Morse in 1878 and was first used in clinically by Von Mering in 1893.
In China, paracetamol has been in used as an analgesic for over 30 years and has been accepted as a very effective drug to relief pain and fever for both adults and children. During the past decades, China has turned from a self-satisfied paracetamol producer to an export-oriented paracetamol supplier in the world.
In 2006, paracetamol has become the dominant variety among traditional bulk medicines in China. A complete paracetamol production chain has formed and all the raw materials including benzene, p-nitrochlorobenzene and PAP can be partially or totally produced in China.
Report Scope
ü Paracetamol
ü paracetamol preparation
ü PAP
ü Aspirin
ü Analgin
ü Ibuprofen
ü Naproxen and Dichlofenac
Why you should buy this report
ü Obtain the latest info of paracetamol, from the aspects of production, trade, raw materials, competitor, price, consumpiton, etc.
ü • Keep you informed of your competitors/their activities in China
ü • Provide powerful assistance to the strategy group and the management team in making correct decisions
Report highlights
There are dozens of NSAIDs in domestic market. Nine of the most frequently used medicines are paracetamol, caffein, aspirin, analgin, ibuprofen, naproxen, dichlofenac, indomatecin, phenacetin. Among all the NSAID medicines, paracetamol is in a dominating position, accounting for around 60% of China’s total NSAID output.
Paracetamol industry of China is faced with competition from India, though China’s output, export and d consumption have all increased in the recent years.
There are currently 16 active paracetamol manufacturers in China with the total capacity of 125,800t/a.
The supply of PAP can meet the demand from paracetamol industry.
Accompanied with the production expansion in China is the sharp price decline in the international market.
In the past ten years, China’s apparent consumption of paracetamol has been increasing at the rate of 15.58% per year.
Shandong Anqiu Lu’an Pharmaceutical Co., Ltd.; Anhui Bayi Chemical Group Bengbu Bayi Chemical Co., Ltd.; Henan Jiaozuo Xin’an Pharmaceutical Co., Ltd.; Tianjin SmithKline; Fortune Pharmacal Co., Ltd.
RELATED REPORTS
There have been new changes to China’s ephedrine industry in recent three years (2004~2006), in output, production method and government's role, etc. In the coming several years, how will the ephedrine industry in China go? You can find the answers after reading this report. The report thoroughly ...
Industries : Pharmaceutical | Countries : China
The report aims to uncover the situation of aspirin in China from aspects of production, import & export, consumption, manufacturers and technology. The report focuses on the bulk aspirin, but the major preparations are also introduced. In addition, the overview of analgesic-antipyretic industry and ...
Industries : Pharmaceutical | Countries : China
In the past ten years, Chinese paracetamol industry developed quickly, its output, export and domestic consumption all increased by over 10%. At the same time, PAP output in China grew quickly with a CAGR of 16.38%. What’s the production cost in China’s paracetamol and PAP producers? What consti ...
Industries : Pharmaceutical | Countries : China
China is the major producer of rutin in the world. China’s supply and demand of rutin seems to have reached a balance in the past years. Due to the growing demand of rutin in oversea market, China’s rutin output will increase in the future. The report looks at China’s rutin in the past(1980s~2 ...
Industries : Pharmaceutical | Countries : China
This report is updated based on CCM’s first edition urotropine report, which was finished in 2004. The report focuses on the production, producer, import & export, consumption, as well as raw material. Once the readers finish reading the report, he/she will have a clear picture of China’s urotro ...
Industries : Pharmaceutical | Countries : China
The aim of this report is to provide basic understanding to the Chinese anhydrous dextrose industry. This report is presented in two parts. The part of production & market information, discusses & summarises the production situation in China from aspects of past production situation, present product ...
Industries : Pharmaceutical | Countries : China
The report is a preliminary study on Glucose industry in China. The production, producers, demand & consumption, end-use segments and import & export are introduced plus a brief summary of corn starch industry and glucose history development. Especially, more than 40 producers, breakdown by active, ...
Industries : Pharmaceutical | Countries : China
China Independent Retail Pharmacies is provides a comprehensive and in-depth examination of the independent and chain drugstore sector in China. Areas of focus include the changing regulatory landscape, business practices and sales models of successful pharmacies, key market drivers and players, an ...
Industries : Pharmaceutical | Countries : China
With a rapidly growing economy, cost advantages, a skilled workforce, and a governmental commitment to the sciences, China is becoming increasingly important in the global biotechnology industry. Successful forays into high technology manufacturing and the increasing prestige of its scientific insti ...
Industries : Pharmaceutical | Countries : China
As the China services industry gains experience, its ability to perform services for the global market while striving to meet international standards has made it a growing presence in preclinical development. Today, leading companies are taking advantage of the opportunities that China presents.Chin ...
Industries : Pharmaceutical | Countries : China
Related industries
reportlinker.com © Copyright 2009. All rights reserved